When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMF - Astellas buys Xyphos to gain immuno-oncology platform talent
Astellas Pharma Inc
Astellas Pharma (OTCPK:ALPMF) (OTCPK:ALPMY) acquires Xyphos, gaining the proprietary Advanced Cellular Control through Engineered Ligands (ACCEL) platform to develop new ways to direct immune cells to find, modulate, and destroy targeted cells throughout the body.
More news on: Astellas Pharma Inc., Astellas Pharma Inc., Healthcare stocks news, Merger & acquisition news,